Drug or treatment
Canakinumab clinical trials
As of November 12, 2026, Find a Trial lists 6 clinical trials of Canakinumab that are recruiting, at sites in 3 countries (most in United States (3), Switzerland (2), Japan (1)). By phase: Phase 2 (3), Phase 3 (1). The most active sponsors are Novartis (2), M.D. Anderson Cancer Center (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Canakinumab use in Schnitzler’s syndrome in real-world patients | — | Kobe, Hyōgo and 4 other locations | Recruiting | May 20, 2026 |
| Canakinumab use in FMF and Still's disease patients across real-world care | — | Basel | Recruiting | Apr 8, 2026 |
| Using canakinumab to prevent cancer in patients with low blood cell counts | Phase 2 | Miami, Florida and 5 other locations | Recruiting | Dec 8, 2022 |
| Canakinumab treatment for low blood sugar after weight loss surgery | Phase 3 | Basel and 1 other locations | Recruiting | Jun 2, 2022 |
| Using canakinumab to prevent lung cancer in high-risk patients | Phase 2 | Houston, Texas | Recruiting | Mar 9, 2021 |
| Treatment of low or intermediate-risk myelodysplastic syndromes and chronic myelomonocytic leukemia with canakinumab | Phase 2 | Houston, Texas | Recruiting | Jan 23, 2020 |
All recruiting trials (6)
-
Canakinumab use in Schnitzler’s syndrome in real-world patients
This study tests how well and how safely canakinumab works for people diagnosed with Schnitzler’s syndrome who are taking it in routine clinical care.
-
Canakinumab use in FMF and Still's disease patients across real-world care
This real-world study looks at how people with FMF or Still's disease who were treated with canakinumab fare over at least 6 months.
-
Using canakinumab to prevent cancer in patients with low blood cell counts
This study is testing if the drug canakinumab can help prevent cancer in people with low blood cell counts and certain genetic changes.
-
Canakinumab treatment for low blood sugar after weight loss surgery
This study is testing if a medication called canakinumab can help people who have had weight loss surgery manage low blood sugar after meals.
-
Using canakinumab to prevent lung cancer in high-risk patients
This study is testing if a medication called canakinumab can help prevent lung cancer in people who have high-risk lung nodules.
-
Treatment of low or intermediate-risk myelodysplastic syndromes and chronic myelomonocytic leukemia with canakinumab
This study is testing if a new medication called canakinumab can help people with low or intermediate-risk myelodysplastic syndromes and chronic myelomonocytic leukemia feel better and reduce their need for blood transfusions.
Quick answers
How many clinical trials of Canakinumab are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), Switzerland (2 trials), Japan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.